➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Harvard Business School
Moodys
McKinsey
Johnson and Johnson

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Litigation Details for ParkerVision, Inc. v. QUALCOMM Incorporated (M.D. Fla. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

ParkerVision, Inc. v. QUALCOMM Incorporated (M.D. Fla. 2014)

Docket   Start Trial Date Filed 2014-05-02
Court District Court, M.D. Florida Date Terminated 2016-02-04
Cause 15:1126 Patent Infringement Assigned To Paul Gregory Byron
Jury Demand Both Referred To
Parties HTC AMERICA, INC.; HTC CORPORATION; PARKERVISION, INC.; QUALCOMM ATHEROS, INC.; QUALCOMM INCORPORATED; SAMSUNG ELECTRONICS AMERICA, INC.; SAMSUNG ELECTRONICS CO., LTD.; SAMSUNG TELECOMMUNICATIONS AMERICA, LLC
Patents 10,064,948; 10,092,738; 10,094,836; 10,095,829; 10,105,435; 10,112,903; 10,118,869; 10,118,881; 10,130,582; 10,131,744; 10,131,907; 10,149,492; 10,149,829; 10,198,903; 10,201,517; 10,251,873; 10,265,370; 10,285,910; 10,309,966; 10,314,864; 10,314,898; 10,314,910; 10,357,148; 10,357,448; 10,357,502; 10,363,324; 10,364,281; 10,369,109; 10,369,110; 10,369,119; 10,369,124; 10,435,452; 10,492,793; 10,508,133; 10,517,881; 10,519,131; 10,519,195; 10,519,211; 10,519,228; 10,537,572; 10,537,580; 10,543,283; 6,110,738; 6,132,793; 6,265,370; 6,319,523; 6,358,504; 6,368,856; 6,500,829; 6,572,873; 6,667,314; 6,713,293; 6,774,104; 6,830,520; 6,830,898; 6,864,228; 6,864,264; 6,869,373; 6,979,829; 7,128,667; 7,147,580; 7,153,473; 7,153,856; 7,198,950; 7,264,835; 7,297,502; 7,309,580; 7,309,707; 7,364,520; 7,368,264; 7,368,564; 7,435,755; 7,452,902; 7,473,171; 7,473,543; 7,510,873; 7,514,415; 7,517,334; 7,517,519; 7,572,198; 7,572,448; 7,572,621; 7,572,783; 7,572,966; 7,582,297; 7,582,621; 7,621,424; 7,667,091; 7,713,255; 7,713,521; 7,713,719; 7,732,135; 7,732,137; 7,738,095; 7,829,081; 7,829,082; 7,829,297; 7,829,309; 7,829,537; 7,841,372; 7,841,950; 7,879,289; 7,879,334; 7,910,131; 7,967,704; 8,092,988; 8,118,802; 8,133,518; 8,133,707; 8,147,873; 8,178,492; 8,178,518; 8,178,519; 8,178,582; 8,198,492; 8,211,879; 8,246,950; 8,246,979; 8,258,371; 8,263,580; 8,283,319; 8,283,368; 8,283,506; 8,309,572; 8,334,265; 8,357,369; 8,357,713; 8,366,910; 8,415,311; 8,415,363; 8,424,518; 8,435,502; 8,452,543; 8,492,319; 8,492,369; 8,510,508; 8,580,264; 8,580,520; 8,580,792; 8,802,103; 8,802,129; 8,802,137; 8,802,881; 8,829,175; 8,829,275; 8,835,452; 8,835,473; 8,835,502; 8,841,258; 8,845,424; 8,940,517; 9,072,836; 9,096,829; 9,096,907; 9,119,903; 9,133,518; 9,149,707; 9,157,907; 9,198,829; 9,198,869; 9,198,966; 9,211,564; 9,265,724; 9,283,195; 9,283,357; 9,284,275; 9,284,369; 9,284,370; 9,284,371; 9,284,543; 9,284,572; 9,285,364; 9,285,372; 9,358,297; 9,364,435; 9,364,473; 9,364,504; 9,364,564; 9,370,802; 9,415,284; 9,452,988; 9,492,283; 9,492,324; 9,492,417; 9,492,506; 9,504,265; 9,504,704; 9,518,106; 9,518,111; 9,518,130; 9,518,167; 9,549,907; 9,549,940; 9,572,856; 9,580,506; 9,580,508; 9,687,517; 9,707,153; 9,707,281; 9,707,293; 9,707,297; 9,713,543; 9,713,572; 9,713,621; 9,719,104; 9,719,108; 9,724,281; 9,724,293; 9,724,297; 9,724,331; 9,724,358; 9,724,381; 9,724,415; 9,724,864; 9,732,107; 9,732,145; 9,732,149; 9,744,129; 9,744,170; 9,744,177; 9,744,285; 9,829,126; 9,841,424; 9,845,350; 9,845,504; 9,849,118; 9,856,265; 9,856,314; 9,856,510; 9,873,667; 9,879,067; 9,879,077; 9,879,088; 9,907,783; 9,907,793; 9,907,802; 9,907,836; 9,907,849
Attorneys Angela J. Crawford; Benjamin Damstedt; Courtney Kneece Grimm; Dena Chen; Douglas Aaron Cawley; Eamonn Gardner; Edward H. Sikorski; Erik Fuehrer; Erin C. Trenda; Howard Wizenfeld; James Arthur Bolling; Jeffrey Scott Karr; Jennifer A. Albert; Jeremy Todd Elman; John Andrew DeVault , III; John R. Thomas; Joshua W. Budwin; Kathy H. Li; Kevin Hamilton; Kevin Hess; Kevin L. Burgess; Lam K. Nguyen; Leah Buratti; Louis J. Freeh; Mario A. Apreotesi; Mark Fowler; Matthew Brigham; Michael E. Lockamy; Michael G. Flanigan; Puneet Kohli; Richard Kamprath; Richter Darryl Burke; Sean C. Cunningham; Stephen C. Neal; Stephen D. Busey; Stephen R. Smith; Timothy S. Teter
Firms Bedell, Dittmar, DeVault, Pillans & Coxe, PA; Cadwalader Wickersham & Taft LLP; Clay County Attorney's Office; Cooley LLP; DLA Piper LLP; DLA Piper US LLP; Freeh, Sporkin, & Sullivan, LLP; McKool Smith, P.C.; Reichman Jorgensen LLP; Smith, Hulsey & Busey; Stephen R. Smith
Link to Docket External link to docket
Biologic Drugs cited in ParkerVision, Inc. v. QUALCOMM Incorporated

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ParkerVision, Inc. v. QUALCOMM Incorporated (M.D. Fla. 2014)

Date Filed Document No. Description Snippet Link To Document
2020-04-29 381 *Order pdf proceed with the following patents and claims: ’940 Patent (10 claims): 24, 25, 26, 331, 364…127 ’907 Patent (7 claims): 1, 2, 10, 13, 14, 15, 23 ’177 Patent (11 claims): 1, 2…. 324-10). ParkerVision did not limit the claims of the ‘177 patent, or even the ‘845 patent, through…range of embodiments disclosed in the patent. (Doc. 334, 105:7–10). ParkerVision argued that even if… response. 10 ParkerVision I involved U.S. Patent No. 7,724,845, and it included External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Harvard Business School
Dow
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.